- Welcome to SynInnova
- +1 780 485 2962
- sales@syninnova.com
- Welcome Guest
About SynInnova
Overview
SynInnova was established in 2008 to provide both early-stage and advanced chemistry services. We serve as a reliable supplier of innovative research chemicals and advanced intermediates to the pharmaceutical, agrochemical, veterinary, and biotechnology sectors, as well as academic research institutions, supporting their drug discovery and product development efforts. As a contract research organization (CRO), SynInnova offers high-quality services in custom synthesis, medicinal chemistry, process design, and development. We can produce target compounds ranging from milligrams to grams according to customers' specifications. The scientific and technology team at SynInnova has extensive knowledge of chemistry and experience in producing a diverse range of research chemicals. The team is committed to maintaining high quality, cost-effectiveness, timely responses, strict confidentiality, and customer support.
Mission
"Our mission is to accelerate drug discovery and biomedical research with innovative chemistry solutions while providing superior value to our customers."
Our Philosophy is to serve our clients to perfection with excellent quality and prompt delivery, and to show high level of innovation by handling hard-to-solve problems with synthetic challenges. Thus, providing better health care to the global community.
Quality
Best quality is our best policy. We never compromise with quality and we continuously work hard to achieve the committed quality of our products. Our motto is meeting the dead line is not enough, beating the deadline is our anticipation.
Personalization
We work closely with our clients according to their specific and individual needs and we strive to achieve their satisfaction. Such performance requires our extra efforts to know a client and understand their business but we take it serious and provide as much freedom as our clients would like to have. All we care is our clients' satisfaction.
Commitment and Transparency
Clients can rely on our guarantees once we make commitment. SynInnova specializes in fine & specialty chemicals, thanks to our technical background and years of experience in chemical industry. Once the commitment is made we will achieve our targets at any cost. Together with strong commitment and highest degree of transparency in our actions we are able to provide one-stop sourcing.
Close Communication to Clients
Close and professional communication with our customers ensures high quality service. SynInnova provides detailed research reports to each customer on a bi-weekly basis. In addition, customers can access up-to-date information online. Finally, frequent tele-conference, with customers further enhance the communication with our clients.
We are dedicated to streamline your research efforts and can provide cost-effective solutions for your chemical needs.
Our team, strict quality controllers, cordial customer support specialists and experienced business professionals dedicated to the high quality, cost-efficiency, timely response and the maximization benefit of our customers.
Babu Nallareddy, M.Sc, Ph.D
Founder, President & CEO
Dr. Nallareddy founded SynInnova in 2008 to pursue his passion, apply his expertise, and support pharmaceutical and biotechnology companies in accelerating drug discovery research. He takes great pride in addressing the challenges involved in establishing and enhancing SynInnova’s reputation in these sectors. Dr. Nallareddy has instilled the core values of quality, reliability, integrity, and collaboration into SynInnova’s culture and business practices.
Prior to founding SynInnova, Dr. Nallareddy served as a Senior Scientist and Team Leader at two prominent contract research organizations (CROs). He played key roles in several collaborations with leading pharmaceutical and biotechnology companies such as Pfizer, Merck, Gilead Sciences, and Anacor. Before entering industry, he was an NSERC-NRC Visiting Fellow in Dr. Prabhat Arya’s group for two years, working in the Chemical Biology Program at the Steacie Institute of Molecular Sciences (SIMS), National Research Council of Canada, Ottawa. His work focused on the diversity-oriented asymmetric synthesis of natural product-inspired benzofuran-based architectures. After completing his graduate studies, he worked for two years with the late Professor A. Srikrishna’s group at the Indian Institute of Science, Bangalore, India, on the total synthesis of natural products and synthetic methodologies. He earned his Ph.D. in Organic Chemistry from Sri Venkateswara University under the supervision of late Professor D. Bhaskar Reddy. His research accomplishments have been published in numerous international, peer-reviewed journals.
Syed M. Baquer, M.Sc, Ph.D
Head Of Chemistry
Dr. Baquer was appointed as Head Of Chemistry at SynInnova in July 2025. Previously, he worked over 20 years at two leading CROs in India, collaborating with top pharmaceutical and biotech companies worldwide.
During his 20-year tenure, he held the position of Director and undertook a range of responsibilities. Dr. Baquer supervised a project team for a European pharmaceutical company and contributed to the identification of two lead molecules as INDs within 3.5 years. He expanded the collaboration from a pilot project to 50 scientists. He was also responsible for managing several smaller FTE and FFS programs.
Before beginning his career, he completed a post-doctoral fellowship in organic chemistry at Umeå University, Sweden, where he worked on synthesizing peptides and long chain glycopeptides for research related to rheumatoid arthritis. He earned his doctorate in organic chemistry at the National Chemical Laboratory in Pune, India, focusing on the synthesis of biologically active compounds. His research work has been published in multiple international peer-reviewed journals.
Marc A. Labroli, Ph.D
Head Of Business Development
Dr. Marc Labroli was appointed Head of Business Development at SynInnova in March 2026. Prior to joining SynInnova, Marc spent over two decades at Merck & Co. and Schering-Plough. Throughout his career, he has been a key contributor to drug discovery programs from initial hit identification through clinical candidate nomination, resulting in over 50 peer-reviewed publications and patents. His work has spanned diverse therapeutic areas, including infectious diseases, oncology, antibacterials, and neuroscience.
Marc has a proven track record in managing external Discovery Chemistry teams, having successfully overseen large groups of external FTEs across international organizations. His experience in project management and multidisciplinary collaboration is instrumental in SynInnova’s mission to provide high-quality chemistry solutions to the global scientific community.
Marc earned his Ph.D. in Chemistry from the University of Virginia and completed his postdoctoral research at The Scripps Research Institute. He also holds a B.S. in Chemistry from Villanova University. Based in the New Jersey area, Marc remains dedicated to accelerating drug discovery through innovation and operational excellence.
Indusha Nallareddy, B.E.
Indusha Nallareddy studied mechanical engineering at the University of Alberta from 2020 to 2025, with 19 months of co-op experience at ATCO. As a co-op student, she managed and prepared pipeline projects for construction to alleviate integrity and operational issues. There, she enjoyed communicating with vendors, contractors, and various cross-functional teams. At SynInnova, she provides communications support to ensure the smooth delivery of projects.